Gujarat Themis Biosyn Reports Nil Deviation in QIP Fund Utilization
Gujarat Themis Biosyn Ltd · Others (Uncategorized) · 14 Nov 2026, 11:31 pm
Gujarat Themis Biosyn Reports Nil Deviation in QIP Fund Utilization Gujarat Themis Biosyn reported nil deviation in the utilization of ₹75,000.00 lakh raised via its QIP completed on 28th Aug'26, as per India Ratings & Research's monitoring report for the quarter ended 30th Sep'26. The company utilized ₹72,700.00 lakh toward inorganic growth via subsidiary Themis Biosyn Japan and ₹213.93 lakh for issue expenses, totaling ₹72,913.93 lakh in total utilization. The unutilized balance of ₹2,086.07 lakh remains deposited across bank escrow and operational accounts, earmarked for remaining issue expenses and general corporate purposes.
Original exchange filing (PDF)
More announcements from Gujarat Themis Biosyn Ltd
- Recording of Analysts Meet held on 16.11.2026 · 17 Nov 2026
- Please refer to the attached Analysts Presentation · 16 Nov 2026
- Please refer to the attachment · 16 Nov 2026
- Please refer to the intimation of resignation of Company Secretary & Compliance Officer. · 15 Nov 2026
- Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2026 · 14 Nov 2026
- Gujarat Themis Biosyn Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Outcome of the Board Meeting held on 14.11.2026 · 14 Nov 2026
- GUJTHEM : 14-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 04, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2026, To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 14 Nov 2026
